Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens

Journal of Biotechnology
Davide SerrutoVega Masignani

Abstract

Since its introduction, vaccinology has been very effective in preventing infectious diseases. However, in several cases, the conventional approach to identify protective antigens, based on biochemical, immunological and microbiological methods, has failed to deliver successful vaccine candidates against major bacterial pathogens. The recent development of powerful biotechnological tools applied to genome-based approaches has revolutionized vaccine development, biological research and clinical diagnostics. The availability of a genome provides an inclusive virtual catalogue of all the potential antigens from which it is possible to select the molecules that are likely to be more effective. Here, we describe the use of "reverse vaccinology", which has been successful in the identification of potential vaccines candidates against Neisseria meningitidis serogroup B and review the use of functional genomics approaches as DNA microarrays, proteomics and comparative genome analysis for the identification of virulence factors and novel vaccine candidates. In addition, we describe the potential of these powerful technologies in understanding the pathogenesis of various bacteria.

References

Aug 1, 1991·Vaccine·P C Turnbull
Jul 28, 1995·Science·R D FleischmannJ M Merrick
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M J MahanJ J Mekalanos
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·J WangS Jin
Nov 1, 1995·Molecular Microbiology·A Camilli, J J Mekalanos
Jul 1, 1997·Molecular Microbiology·G M Young, V L Miller
Sep 19, 1997·Trends in Microbiology·R H Valdivia, S Falkow
Jan 13, 1998·Current Opinion in Biotechnology·M A Andrade, C Sander
Apr 16, 1998·Molecular Microbiology·A M LoweR L Deresiewicz
Jan 23, 1999·Nature Genetics·V G CheungG Childs
Jan 23, 1999·Nature Genetics·R J LipshutzD J Lockhart
Jan 23, 1999·Nature Genetics·P O Brown, D Botstein
Mar 6, 1999·Current Opinion in Microbiology·D L Brutlag
May 5, 1999·JAMA : the Journal of the American Medical Association·J W TapperoB A Perkins
Aug 18, 1999·Electrophoresis·P R JungblutG Stöffler
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·M WilsonG K Schoolnik
Feb 16, 2000·Electrophoresis·H LangenM Fountoulakis
Feb 7, 2001·The Journal of Biological Chemistry·P CohenP Casellas
Jun 24, 2000·Nature·D J Lockhart, E A Winzeler
Aug 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·J K IchikawaS Lory
Aug 30, 2000·Nature·C M FraserS L Salzberg
Sep 15, 2000·Journal of Bacteriology·V PelicicX Nassif
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E T Ryan, S B Calderwood
Sep 22, 2000·Emerging Infectious Diseases·C A Cummings, D A Relman
Oct 26, 2000·Current Opinion in Microbiology·R Rappuoli
Nov 4, 2000·Nature Medicine·Y H SunC M Tang
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·C E BelcherD A Relman
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·N SalamaS Falkow

❮ Previous
Next ❯

Citations

Jun 15, 2006·Functional & Integrative Genomics·Tim T BinnewiesDavid W Ussery
Apr 14, 2005·International Journal for Parasitology·E A Worthey, P J Myler
Apr 7, 2005·Nature Medicine·Stanley A Plotkin
Jun 1, 2013·Briefings in Functional Genomics·Elena Del Tordello, Davide Serruto
Nov 12, 2010·Immunome Research·Darren R FlowerIrini A Doytchinova
Jul 6, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Andrew Preston
Oct 15, 2013·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·A GilJ A Vázquez
Sep 26, 2008·Trends in Biochemical Sciences·Robert J Fieldhouse, A Rod Merrill
Mar 29, 2008·Veterinary Microbiology·Abdolreza Reza Movahedi, David J Hampson
Nov 1, 2005·Drug Discovery Today·Vincent W Bramwell, Yvonne Perrie
Jul 5, 2005·Drug Discovery Today·Christoph Freiberg, Heike Brötz-Oesterhelt
May 20, 2015·Pathologie-biologie·M LecaP Vanelle
Jan 15, 2015·Enfermedades infecciosas y microbiología clínica·Sara QueroMiquel Sabrià
Jul 9, 2011·Experimental Biology and Medicine·Britta Denman, Steven R Goodman
Dec 9, 2014·Reproduction, Fertility, and Development·Aleona Swegen, R John Aitken
Jul 14, 2007·Proteomics·Giulia BernardiniAnnalisa Santucci
Dec 20, 2012·Expert Review of Vaccines·Veerakyathappa BhanuprakashRaj Kumar Singh
Oct 19, 2007·Expert Review of Proteomics·Giulia BernardiniAnnalisa Santucci
Apr 14, 2005·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J A Soult Rubio, M Muñoz Sáez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

© 2021 Meta ULC. All rights reserved